Australian life sciences and health products company Bioxyne Limited (ASX:BXN) has launched three new products for the Asian market following the grant of a Direct Sales Licence in Malaysia.
BEssence – to reduce fine lines and wrinkles
Managing Director NH Chua said the company has used the fact that the products are formulated and manufactured in the clean and environmentally green New Zealand as a major selling point.
“In bringing these new products to market it is important to us to ensure that they have the utmost integrity and represents the best that New Zealand has to offer to Asia,” Mr Chua said.
“Our distributor base has been eagerly awaiting these products and with the infrastructure now in place we look forward to gathering sales momentum as we move into 2018.”
Direct sales marketing in Malaysia is estimated to be US$4 billion and is one of the fastest growing direct sales markets in Asia.
The company is also developing direct sales business in other Asian countries, including obtaining Direct Sales Licences where appropriate.
These countries include Vietnam (direct sales market estimated at US$0.4 billion), Taiwan (direct sales estimated at US$3.3 billion) and Indonesia (direct sales estimated at US$1 billion).
The commencement of marketing of all products in Malaysia, has also been boosted by an initial order of 16,000 cans of BK18 for South East Asian countries outside of Malaysia.
Mr Chua said Bioxyne also has a good pipeline of exciting new products under development. These new products are scheduled for release in early 2018.
